Medical device company focused on improving patient outcomes through enabling rapid soft tissue tensioning and fixation. Tesa’s proprietary technology platform, allows for the rapid tensioning and fixation of soft tissue thereby enabling physicians to mitigate downstream consequences that currently affect as many as 40% of patients.